This is a different regulatory category from prescription GLP-1 drugs such as Wegovy and Mounjaro, which are MHRA-licensed medicines that have undergone full clinical assessment
Pricing, availability, and program details are subject to change
Option 1: Get a prescription from licensed physician Pathway: Visit doctor (in-person or telehealth) Discuss medical need Get prescription Fill at compounding pharmacy Advantages: Completely legal Medical oversight Prescription-grade quality Insurance might cover (depends on peptide and diagnosis) Disadvantages: More expensive than research chemicals Requires medical justification Not all doctors willing to prescribe Option 2: Peptide therapy clinic Pathway: Find clinic specializing in peptide therapy Initial consultation Medical evaluation Prescription and treatment plan Ongoing monitoring Advantages: Doctors experienced with peptides Comprehensive protocols Legal and legitimate Quality assured Disadvantages: Expensive (consultation fees + peptide costs) May require ongoing visits Not available everywhere Find clinics in our peptide therapy clinics guide
The NIHR 'Be Part of Research' service is the recommended starting point for patients seeking legitimate trial access
Spiazzi BF, Naibo RA, Wayerbacher LF, Piccoli GF, Farenzena LP, Londero TM, da Natividade GR, Zoldan M, Degobi NAH, Niches M, Lopes G, Boyko EJ, Utzschneider KM, Colpani V, Gerchman F
